Clinical Trial Update: Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing narrowband UVB light therapy in dark-skinned patients with 10% body involvement of psoriasis vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Narrowband UVB Light Therapy

Snippet

Sponsor: Mary Sullivan-Whalen | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED